Fig. 1From: Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitorsAn overview of predictive biomarkers for immune checkpoint inhibitors efficacy. Key elements in predictive biomarker development for the efficacy of immune checkpoint inhibitors therapy are briefly described in the figure, including tumor cells-related biomarkers, tumor immune microenvironment phenotype biomarkers, circulating factors, host-related factors, and immune-related adverse eventsBack to article page